United Kingdom· GB-APID-40086011000001105
Evrenzo 50mg tablets
A roxadustat product containing roxadustat, registered in United Kingdom by Astellas Pharma Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Roxadustat is registered in 13 of 19 countries.
Countries holding a registration under ATC B03XA05 (roxadustat), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Roxadustat · ATC B03XA05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of roxadustat costs, country by country.
Normalised to the WHO defined daily dose (43 mg), the median price runs from $23.73 in Italy to $77.81 in France — a ×3.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Roxadustat · price per daily dose (43 mg)
USD · FX 28 Sept 2026
- FR France$77.81
- IT Italy$23.73
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Roxadustat
- Manufacturer
- Astellas Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- B03XA05
- ATC class
- Roxadustat
- Defined daily dose
- 43 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5013346004392
- gtin05013346004392
- gtin5391509402446
- gtin05391509402446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Roxadustat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEvrenzoAstellas Pharma Europe B.V.
- CzechiaEVRENZOAstellas Pharma Europe B.V., Leiden
- FranceEVRENZO 100 mg, comprimé pelliculéASTELLAS PHARMA EUROPE (PAYS-BAS)
- SwedenEvrenzo 100 mg Filmdragerad tablettAstellas Pharma Europe BV
- SpainEVRENZO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstellas Pharma Europe B.V.
- BelgiumEvrenzo 100 mgAstellas Pharma Europe
- IrelandEvrenzo 100 mg Film-coated tabletAstellas Pharma Europe B.V.
- IcelandEvrenzoAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evrenzo
- Liechtenstein · Evrenzo
- Norway · Evrenzo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e566f728-cc1c-47c3-be04-521fd22c96c4 GET /v1/drugs/e566f728-cc1c-47c3-be04-521fd22c96c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40086011000001105",
"desc": "Evrenzo 50mg tablets (Astellas Pharma Ltd)",
"form": "Oral tablet",
"vpid": "40110811000001108",
"source": "dmd",
"vtm_id": "1287448000",
"strength": "50 mg",
"substance": "Roxadustat",
"ingredient": "Roxadustat",
"supplier_code": "2066301000001100"
}See everything about roxadustat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.